Company
United StatesPublic company, NASDAQ: GERNGeron Corporation (NASDAQ: GERN), Foster City, CA – FDA Inspections
Inspection records and compliance data for Geron Corporation in Foster City, CA. 1 FDA inspection on record, 1 Form 483, last inspected August 14, 2026. Publicly traded as NASDAQ: GERN.
Company Profile
This profile covers Geron Corporation based in Foster City, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected August 14, 2026.
Most cited issue areas
- Failure to develop written procedures1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 14, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1331584 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Geron Corporation
Stock ticker
GERN
Exchange
NASDAQ
Share price
$0.99
Market cap
$640.4M
Price as of
November 13, 2026
FEI Number
3016772438
Address
919 E Hillsdale Blvd Ste 250, Foster City, CA 94404-3296, United States
Country
United States
ID: f3dace20-4cd8-4193-86bc-9f62d11576de